RE:Wasagastar wrote:Thanks Phil - appreciated. Fact of the matter is this could be uncharted territory. The treatment is a two part procedure with instant results. Is anyone expecting different results in phase 2? It's science, now predictive science. FDA/HC needs to work with Theralase to move the second trial along quickly. Their job is to save lives and improve care - exactly what this treatment does. Uncommon results require better than "get in line" treatment.